Merck KGaA to Invest EUR18 Million in Swiss Laboratory
July 15 2020 - 10:14AM
Dow Jones News
By Cecilia Butini
Merck KGaA said Wednesday that it plans to spend 18 million
euros ($20.5 million) to build a new laboratory in Buchs,
Switzerland, to expand its reference-materials business and its
research-and-development sector.
The German pharmaceutical, chemical and life-sciences company
said the expansion will create about two dozen new jobs. The
laboratory will be finished by the end of 2021 and 40 employees
will move into the building at the beginning of 2022, the company
said.
According to Merck, the facility will add to an existing
production hub in Buchs, where the company already produces
reference materials and bioanalytical reagents, among other
products, employing 450 people.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
July 15, 2020 09:59 ET (13:59 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Dec 2020 to Jan 2021
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Jan 2020 to Jan 2021